BioMarin Pharmaceutical (BMRN)

BioMarin Pharmaceutical (BMRN) Income Statement


BioMarin Pharmaceutical Income Statement

Last quarter (Q4 2023), BioMarin Pharmaceutical's total revenue was $646.21M, an increase of 20.22% from the same quarter last year. In Q4, BioMarin Pharmaceutical's net income was $20.38M. See BioMarin Pharmaceutical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 2.41B$ 2.42B$ 2.10B$ 1.85B$ 1.86B$ 1.70B
Cost of Revenue
$ 530.52M$ 514.85M$ 483.67M$ -470.51M$ 524.27M$ 359.47M
Gross Profit
$ 1.90B$ 1.90B$ 1.61B$ 1.31B$ 1.34B$ 1.34B
Operating Expense
$ 2.21B$ 2.21B$ 1.51B$ 1.38B$ 1.43B$ 1.45B
Operating Income
$ 181.60M$ 158.10M$ 149.56M$ -70.50M$ -91.83M$ -104.83M
Net Non Operating Interest Income Expense
$ 41.00M$ 41.00M$ 2.06M$ -4.86M$ -12.70M$ -712.00K
Other Income Expense
$ -126.60M$ 12.60M$ 375.67M-$ 62.14M$ 10.76M
Pretax Income
$ 188.56M$ 188.56M$ 149.58M$ -75.35M$ -42.32M$ -94.81M
Tax Provision
$ 20.92M$ 20.92M$ 8.02M$ -11.27M$ -901.42M$ -70.96M
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
$ 199.01M$ 167.65M$ 275.95M$ -64.08M$ 859.10M$ -23.85M
Basic EPS
$ 0.89$ 0.89$ 0.76$ -0.35$ 4.75$ -0.13
Diluted EPS
$ 0.88$ 0.87$ 0.75$ -0.35$ 4.53$ -0.13
Basic Average Shares
$ 751.34M$ 187.83M$ 185.27M$ 182.85M$ 180.80M$ 179.04M
Diluted Average Shares
$ 766.38M$ 191.59M$ 188.96M$ 182.85M$ 191.68M$ 179.04M
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
Rent Expense Supplemental
Total Expenses
$ 2.74B$ 2.72B$ 1.99B$ 905.81M$ 1.95B$ 1.81B
Net Income From Continuing And Discontinued Operation
$ 167.65M$ 167.65M$ 141.56M$ -64.08M$ 859.10M$ -23.85M
Normalized Income
$ 405.92M$ 715.03M$ 493.83M-$ 818.95M$ -27.06M
Interest Expense
----$ 27.48M$ 23.46M
$ 205.90M$ 205.90M$ 165.55M$ -60.01M$ -14.84M$ -71.35M
$ 305.24M$ 305.24M$ 274.68M$ 57.33M$ 90.33M$ 33.95M
Currency in USD

BioMarin Pharmaceutical Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis